Literature DB >> 9988699

A new model of dual interacting ligand binding sites on integrin alphaIIbbeta3.

D D Hu1, C A White, S Panzer-Knodle, J D Page, N Nicholson, J W Smith.   

Abstract

The platelet integrin alphaIIbbeta3 mediates platelet aggregation and platelet adhesion. This integrin is the key to hemostasis and also to pathologic vascular occlusion. A key domain on alphaIIbbeta3 is the ligand binding site, which can bind to plasma fibrinogen and to a number of Arg-Gly-Asp (RGD)-type ligands. However, the nature and function of the ligand binding pocket on alphaIIbbeta3 remains controversial. Some studies suggest the presence of two ligand binding pockets, whereas other reports indicate a single binding pocket. Here we use surface plasmon resonance to show that alphaIIbbeta3 contains two distinct ligand binding pockets. One site binds to fibrinogen, and a separate site binds to RGD-type ligands. More importantly, however, the two ligand binding pockets are interactive. RGD-type ligands are capable of binding to alphaIIbbeta3 even when it is already occupied by fibrinogen. Once bound, RGD-type ligands induce the dissociation of fibrinogen from alphaIIbbeta3. This allosteric cross-talk has important implications for anti-platelet therapy because it suggests a novel approach for the dissolution of existing platelet thrombi.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9988699     DOI: 10.1074/jbc.274.8.4633

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Multi-step fibrinogen binding to the integrin (alpha)IIb(beta)3 detected using force spectroscopy.

Authors:  Rustem I Litvinov; Joel S Bennett; John W Weisel; Henry Shuman
Journal:  Biophys J       Date:  2005-07-22       Impact factor: 4.033

2.  Proinflammatory secreted phospholipase A2 type IIA (sPLA-IIA) induces integrin activation through direct binding to a newly identified binding site (site 2) in integrins αvβ3, α4β1, and α5β1.

Authors:  Masaaki Fujita; Kan Zhu; Chitose K Fujita; Min Zhao; Kit S Lam; Mark J Kurth; Yoko K Takada; Yoshikazu Takada
Journal:  J Biol Chem       Date:  2014-11-14       Impact factor: 5.157

3.  Binding of a fibrinogen mimetic stabilizes integrin alphaIIbbeta3's open conformation.

Authors:  R R Hantgan; M Rocco; C Nagaswami; J W Weisel
Journal:  Protein Sci       Date:  2001-08       Impact factor: 6.725

4.  Internal binding of halogenated phenols in dehaloperoxidase-hemoglobin inhibits peroxidase function.

Authors:  Matthew K Thompson; Michael F Davis; Vesna de Serrano; Francesco P Nicoletti; Barry D Howes; Giulietta Smulevich; Stefan Franzen
Journal:  Biophys J       Date:  2010-09-08       Impact factor: 4.033

Review 5.  Platelet integrin alphaIIbbeta3-ligand interactions: what can we learn from the structure?

Authors:  T Kamata; Y Takada
Journal:  Int J Hematol       Date:  2001-12       Impact factor: 2.490

6.  The platelet integrin alphaIIbbeta3 binds to the RGD and AGD motifs in fibrinogen.

Authors:  Juan Sánchez-Cortés; Milan Mrksich
Journal:  Chem Biol       Date:  2009-09-25

7.  Elevating local concentrations of GPIIb-IIIa antagonists counteracts platelet thrombus stability.

Authors:  Henry E Speich; Ronit R Furman; Lindsey T Lands; Geoffrey D Moodie; Lisa K Jennings
Journal:  J Thromb Thrombolysis       Date:  2013-07       Impact factor: 2.300

8.  Functional binding of hexanucleotides to 3C protease of hepatitis A virus.

Authors:  Bärbel S Blaum; Winfried Wünsche; Andrew J Benie; Yuri Kusov; Hannelore Peters; Verena Gauss-Müller; Thomas Peters; Georg Sczakiel
Journal:  Nucleic Acids Res       Date:  2011-12-10       Impact factor: 16.971

9.  TGFbeta1 signaling via alphaVbeta6 integrin.

Authors:  Martin P Kracklauer; Christian Schmidt; Guido M Sclabas
Journal:  Mol Cancer       Date:  2003-08-07       Impact factor: 27.401

10.  Structural basis for distinctive recognition of fibrinogen gammaC peptide by the platelet integrin alphaIIbbeta3.

Authors:  Timothy A Springer; Jianghai Zhu; Tsan Xiao
Journal:  J Cell Biol       Date:  2008-08-18       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.